Join Mini Med School “deans” Laurel W. Rice, MD, and Rebecca Minter, MD, in welcoming our featured speakers. This session's topic is "Alzheimer ’s disease: breakthroughs in diagnosis, treatment and care."
Registration is now full for this Mini Med School Session, however, you can watch the event streaming live on your computer or mobile device on Wednesday, Sept. 18, beginning at 6:30 p.m.
Thank you for your interest in Mini Med School. Look for information about our 2020 programs coming soon. You can view recordings of past Mini Med School programs in our online video library.
Dr. Nathaniel Chin, MD
Dr. Chin is a board-certified internist and geriatrician and Assistant Professor (CHS) of Geriatric Medicine at the University of Wisconsin School of Medicine and Public Health. He received his medical degree from the School of Medicine and Public Health, completed his internal medicine residency at the University of California-San Diego, and completed his Geriatric Medicine fellowship at the School of Medicine and Public Health. He created and participated in the first Geriatric Medicine based Memory and Dementia fellowship at the School of Medicine and Public Health. Dr. Chin joined the Wisconsin Alzheimer’s Disease Research Center and the University of Wisconsin Hospital and Clinics in 2017. He grew up in Watertown, Wisconsin. During his internal medicine residency Dr. Chin’s father was diagnosed with mild stage Alzheimer’s disease dementia. His father’s condition influenced the way he began to look at his own career and life, leading him and his wife to move back to Wisconsin to be with family. Dr. Chin decided to pursue a career as a geriatrician and scientist focused on dementia, specifically Alzheimer's disease.
Andrea Gilmore-Bykovskyi, PhD, RN
Dr. Gilmore-Bykovskyi studies clinical care delivery and health disparities among people living with, and at risk for Alzheimer’s disease and related dementias. She leads an interdisciplinary research program focused on promoting access to effective dementia-specific therapies by improving identification of dementia and enhancing delivery of individualized care to optimize patient and caregiver-centered outcomes. Her research focuses on targeting high-risk points in the care continuum, such as hospitalization and transitions in care, as well as high-risk, disadvantaged groups. Dr. Gilmore-Bykovskyi is particularly interested in the role of non-cognitive symptoms in the recognition, progression and management of dementia, with a particular interest in integrated pain and behavioral symptom management interventions.
Cynthia Carlsson, MD, MS
Dr. Carlsson is the Louis A. Holland, Sr., Professor in Alzheimer’s disease and director of the Wisconsin Alzheimer’s Institute. As a geriatrician at the Madison VA hospital, she treats veterans with dementia and memory issues. Dr. Carlsson studies the effects of midlife vascular risk factors, such as high cholesterol and hypertension, and their association with an increased risk for developing Alzheimer’s disease later in life. Her BRAVE study evaluates fish oil’s effectiveness in stopping or delaying Alzheimer’s disease-related brain changes in veterans.
Sterling C. Johnson, PhD
Dr. Johnson is the Jean R. Finley Professor of Geriatrics and Dementia, associate director of the Wisconsin Alzheimer Disease Research Center, associate director of the Wisconsin Alzheimer’s Institute and principal investigator for the Wisconsin Registry for Alzheimer’s Prevention. Dr. Johnson is a clinical neuropsychologist and neuroimaging researcher focused on understanding how brain changes unique to Alzheimer’s disease affect memory and cognition. He is particularly interested in the early stages of Alzheimer’s disease, before people experience symptoms, and studies this presymptomatic stage using biomarkers obtained through brain imaging and cerebrospinal fluid collection.